Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Carlyle-Backed Claris Lists Below Issue Price
Carlyle-backed pharma company Claris Lifesciences made a poor debut, listing 1.6% below issue price which itself was cut sharply from ......
Healthcare
Aureos Capital India Invests $10M In BSR Super Speciality Hospitals
Indian private equity firm Aureos Capital India has made an investment of $10 million in Central India-based BSR Super Speciality ......
Healthcare
Aventis Pharma Sells 49% In Vaccine JV
French drugmaker Sanofi-Aventis has decided to sell its 49% stake held in a Indian joint venture (Chiron Behring Vaccines Pvt ......
Healthcare
UK's Reckitt Benckiser To Buy Paras Pharma For $726M
Global consumer goods major Reckitt Benckiser Group plc has acquired private equity controlled Paras Pharmaceuticals fo Rs 3,260 crore or ......
Healthcare
Evolvence Life Sciences Fund Invests Rs 40Cr In Fermenta Biotech
Evolvence India Life Sciences Fund (EILSF), a fund focused on investing in the life sciences space in India, is picking ......
Healthcare
Opto Buys 76% Stake In Cardiac Science Corporation
Banglore-based Opto Circuits (India), which is into of medical devices with consolidated revenue of $243 million (Rs 1077 crore), has ......
Healthcare
Jubilant Life Sciences To Demerge Agri, Polymers Biz
General Atlantic-backed Jubilant Life Sciences Limited, earlier known as Jubilant Organosys Ltd.), has demerged its agri & performance polymers business ......
Healthcare
Govt To Set Up Rs 2,000Cr Pharma Fund
The Indian government is in the process of starting a venture capital(VC) fund to support new drug research initiatives in ......
Healthcare
Claris Life Cuts IPO Price Band, Extends Issue Close
India's Claris Lifesciences Ltd has cut price band and extended the closing date for its 3-billion rupee initial public offering, ......
Healthcare
Dr Reddy's Buys Out GSK's Penicillin Facilities, 2 Brands In The US
Indian pharma major Dr Reddy's Laboratories has acquired the United States oral penicillin facility and product portfolio of GlaxoSmithKline plc. This will ......